Key result
Levosimendan boosts basilar artery vasorelaxation post-SAH to ~64% versus ~10% for control.
Why the study?
Levosimendan has anti-inflammatory effects in severe heart failure, but its potential anti-inflammatory role on cerebral vasculature after aneurysmal subarachnoid hemorrhage was unknown.
Does levosimendan antagonize serotonin- and prostaglandin F2alpha-mediated cerebral vasoconstriction and enhance vasorelaxation in rat basilar artery segments after experimental subarachnoid hemorrhage?
Does levosimendan antagonize serotonin- and prostaglandin F2alpha-mediated cerebral vasoconstriction and enhance vasorelaxation in rat basilar artery segments after experimental subarachnoid hemorrhage?
This preclinical study demonstrates that levosimendan exerts spasmolytic effects against serotonin- and PGF2a-induced cerebral vasoconstriction after experimental subarachnoid hemorrhage, supporting its potential utility in SAH patients with delayed cerebral vasospasm or concurrent takotsubo cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support preclinical investigation of levosimendan in SAH vasospasm; hypothesis-generating, should not yet change practice.
BACKGROUND: Poor patient outcomes after aneurysmal subarachnoid hemorrhage (SAH) occur due to a multifactorial process, mainly involving cerebral inflammation (CI), delayed cerebral vasospasm (DCVS), and delayed cerebral ischemia, followed by neurodegeneration. CI is mainly triggered by enhanced synthesis of serotonin (5-HT), prostaglandin F2alpha (PGF2a), and cytokines such as interleukins. Levosimendan (LV), a calcium-channel sensitizer, has already displayed anti-inflammatory effects in patients with severe heart failure. Therefore, we wanted to elucidate its potential anti-inflammatory role on the cerebral vasculature after SAH. METHODS: Experimental SAH was induced by using an experimental double-hemorrhage model. Sprague Dawley rats were harvested on day 3 and day 5 after the ictus. The basilar artery was used for isometric investigations of the muscular media tone. Vessel segments were either preincubated with LV or without, with precontraction performed with 5-HT or PGF2a followed by application of acetylcholine (ACh) or LV. RESULTS: 79%) segments showed greater vasorelaxation compared with sham. An LV series after PGF2a precontraction showed significantly enhanced relaxation in the sham (P=0.004) and SAH groups (P=0.0008) compared with solvent control vessels. CONCLUSIONS: LV application after SAH seems to beneficially influence DCVS by antagonizing 5-HT- and PGF2a-triggered vasoconstriction. Considering this spasmolytic effect, LV might have a role in the treatment of SAH, additionally in selected patients suffering takotsubo cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Wanderer et al. (2021) studied Experimental aneurysmal subarachnoid hemorrhage (SAH) and delayed cerebral vasospasm (n=24). Levosimendan vs. Solvent control (segments without levosimendan) was evaluated on Maximal vasorelaxation (Emax) of PGF2a-precontracted basilar artery segments in the SAH day 3 group (p=0.0008). Levosimendan enhanced maximal vasorelaxation in PGF2a-precontracted basilar artery segments after experimental SAH compared with solvent control.
Synapse has enriched 10 related papers. Consider them for comparative context: